Harbour Investments’s Vaxcyte PCVX Stock Holding History

Harbour Investments’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28K	Buy	22 +10	+83%	+$543	﹤0.01%	4162
2026 Q1	$697	Sell	12 -66	-85%	-$3.58K	﹤0.01%	4187
2025 Q4	$3.6K	Sell	78 -1	-1%	-$45	﹤0.01%	3141
2025 Q3	$2.85K	Sell	79 -9	-10%	-$298	﹤0.01%	3173
2025 Q2	$2.86K	Buy	+88	New	+$2.88K	﹤0.01%	3035

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Harbour Investments's PCVX Position: Q2 2026 in Review

Harbour Investments increased its Vaxcyte (PCVX) stake by 83% in Q2 2026, buying an estimated $543 and bringing the position to 22 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #4162.

Harbour Investments first reported a position in PCVX in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.6K in Q4 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Harbour Investments held 22 shares of Vaxcyte worth $1.28K as of Q2 2026.
Harbour Investments bought 10 Vaxcyte shares in Q2 2026, an estimated $543.
Vaxcyte made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4162 holding.
Harbour Investments first reported a position in Vaxcyte in Q2 2025 and has held it in 5 quarters since.
Harbour Investments's Vaxcyte position peaked at $3.6K in Q4 2025.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.